Literature DB >> 31373360

On restricted optimal treatment regime estimation for competing risks data.

Jie Zhou1, Jiajia Zhang1, Wenbin Lu2, Xiaoming Li3.   

Abstract

It is well accepted that individualized treatment regimes may improve the clinical outcomes of interest. However, positive treatment effects are often accompanied by certain side effects. Therefore, when choosing the optimal treatment regime for a patient, we need to consider both efficacy and safety issues. In this article, we propose to model time to a primary event of interest and time to severe side effects of treatment by a competing risks model and define a restricted optimal treatment regime based on cumulative incidence functions. The estimation approach is derived using a penalized value search method and investigated through extensive simulations. The proposed method is applied to an HIV dataset obtained from Health Sciences South Carolina, where we minimize the risk of treatment or virologic failures while controlling the risk of serious drug-induced side effects.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Competing risks data; Cumulative incidence function; Optimal treatment regime; Side effects; Value search method

Mesh:

Year:  2021        PMID: 31373360      PMCID: PMC8036005          DOI: 10.1093/biostatistics/kxz026

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  23 in total

1.  Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.

Authors:  John P Klein; Per Kragh Andersen
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

2.  Semiparametric analysis of mixture regression models with competing risks data.

Authors:  Wenbin Lu; Limin Peng
Journal:  Lifetime Data Anal       Date:  2008-01-12       Impact factor: 1.588

Review 3.  Review of the impact of NNRTI-based HIV treatment regimens on patient-reported disease burden.

Authors:  Kit N Simpson; Kristin A Hanson; Gale Harding; Seema Haider; Margaret Tawadrous; Alexandra Khachatryan; Chris L Pashos; Albert W Wu
Journal:  AIDS Care       Date:  2013-10-10

4.  DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY.

Authors:  Runchao Jiang; Wenbin Lu; Rui Song; Michael G Hudgens; Sonia Naprvavnik
Journal:  Ann Appl Stat       Date:  2017-10-05       Impact factor: 2.083

5.  A Massive Data Framework for M-Estimators with Cubic-Rate.

Authors:  Chengchun Shi; Wenbin Lu; Rui Song
Journal:  J Am Stat Assoc       Date:  2018-06-19       Impact factor: 5.033

6.  Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.

Authors:  Xiaofei Bai; Anastasios A Tsiatis; Wenbin Lu; Rui Song
Journal:  Lifetime Data Anal       Date:  2016-08-01       Impact factor: 1.588

7.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

8.  Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

Authors:  S Staszewski; J Morales-Ramirez; K T Tashima; A Rachlis; D Skiest; J Stanford; R Stryker; P Johnson; D F Labriola; D Farina; D J Manion; N M Ruiz
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

Review 9.  Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Authors:  Álvaro H Borges; Andreas Lundh; Britta Tendal; John A Bartlett; Nathan Clumeck; Dominique Costagliola; Eric S Daar; Patrícia Echeverría; Magnus Gisslén; Tania B Huedo-Medina; Michael D Hughes; Katherine Huppler Hullsiek; Paul Khabo; Stephanus Komati; Princy Kumar; Shahin Lockman; Rodger D MacArthur; Franco Maggiolo; Alberto Matteelli; Jose M Miro; Shinichi Oka; Kathy Petoumenos; Rebekah L Puls; Sharon A Riddler; Paul E Sax; Juan Sierra-Madero; Carlo Torti; Jens D Lundgren
Journal:  Clin Infect Dis       Date:  2016-04-18       Impact factor: 9.079

10.  On Estimation of Optimal Treatment Regimes For Maximizing t-Year Survival Probability.

Authors:  Runchao Jiang; Wenbin Lu; Rui Song; Marie Davidian
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2016-09-02       Impact factor: 4.488

View more
  2 in total

1.  Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.

Authors:  Yizeng He; Soyoung Kim; Mi-Ok Kim; Wael Saber; Kwang Woo Ahn
Journal:  Comput Stat Data Anal       Date:  2021-01-14       Impact factor: 2.035

2.  CAPITAL: Optimal subgroup identification via constrained policy tree search.

Authors:  Hengrui Cai; Wenbin Lu; Rachel Marceau West; Devan V Mehrotra; Lingkang Huang
Journal:  Stat Med       Date:  2022-07-07       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.